Jilin Luwang Pharmaceutical Co., Ltd. is a state-owned pharmaceutical enterprise integrating the research, development, production and sales of patent medicines, Western medicines and Chinese herbal medicines.

Founded in 1982, it was formerly the Longtanshan Pharmaceutical Factory in Jilin City, and is now a wholly-owned subsidiary of Jilin Chemical Fiber. The company has more than 380 employees, including 1 doctorate, 3 master’s degree, 37 bachelor’s degree, 43 junior college degree, and more than 10% of professional and technical management personnel at junior and above. The assets are 320 million yuan and the annual output value is 180 million yuan. Through the past 40 years of development, we have accumulated profound brand advantages of Chinese and Western patent medicines and mature market channels, and our products are welcomed and favored by consumers.

The company mainly uses Chinese patent medicines and supplemented by Western medicines. It has 155 documents and 127 varieties of products. It covers 6 dosage forms such as tablets, hard capsules, pills, granules, powders, decoctions, and Chinese herbal decoctions (pure). Cut, cut). Among them, there are 110 Chinese patent medicines and 45 Western medicines. The flagship products include: Nephritis Shu, Lu Fei Paste, Dingkun Dan, Baihe Gujin Pills, Lixin Pills, Sanshen Pills, Compound Baotai Grouse Blood Vine Tablets, etc. Among them, Nephritis Shuhe Lixin Pills are national traditional Chinese medicine protected varieties.

The company has always adhered to the business philosophy of practicing conscience and craftsmanship and state-owned enterprises, and has deeply explored the aspects of product research and development, quality assurance, channel expansion, platform construction, health management, etc., and inherited the "dedication, dedication, responsibility, innovation, and self-discipline of Jilin Chemical Fiber. "The five spirits of enterprises, build a solid foundation for development with quality and efficacy, and build a conscientious brand of China's big health industry.